Achieve Life Sciences Inc (ACHV) — Cash Flow-to-Debt Ratio
Achieve Life Sciences Inc (ACHV) has a Cash Flow-to-Debt Ratio of -0.31x as of March 2026, meaning its operating cash flow of $-6.93 Million could theoretically repay 0% of its total liabilities ($22.43 Million) in one year. See Achieve Life Sciences Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Achieve Life Sciences Inc Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Achieve Life Sciences Inc across 32 annual periods. For the full cash flow conversion analysis, see ACHV operating cash flow.
Annual Cash Flow-to-Debt Ratio for Achieve Life Sciences Inc (1994–2025)
Year-by-year debt coverage analysis for Achieve Life Sciences Inc. Check ACHV operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.44x | $-49.47 Million | $20.27 Million | ▼ -45.4% |
| 2024 | -1.68x | $-29.77 Million | $17.73 Million | ▼ -42.8% |
| 2023 | -1.18x | $-24.48 Million | $20.82 Million | ▲ +32.2% |
| 2022 | -1.73x | $-37.57 Million | $21.67 Million | ▼ -14.7% |
| 2021 | -1.51x | $-29.44 Million | $19.47 Million | ▲ +66.2% |
| 2020 | -4.47x | $-13.47 Million | $3.01 Million | ▲ +11.0% |
| 2019 | -5.03x | $-15.22 Million | $3.03 Million | ▼ -55.3% |
| 2018 | -3.24x | $-10.62 Million | $3.28 Million | ▲ +28.5% |
| 2017 | -4.52x | $-9.11 Million | $2.01 Million | ▼ -29.6% |
| 2016 | -3.49x | $-29.68 Million | $8.50 Million | ▼ -696.5% |
| 2015 | -0.44x | $-9.10 Million | $20.77 Million | ▲ +43.7% |
| 2014 | -0.78x | $-17.31 Million | $22.23 Million | ▲ +60.0% |
| 2013 | -1.94x | $-35.93 Million | $18.48 Million | ▲ +29.3% |
| 2012 | -2.75x | $-43.49 Million | $15.81 Million | ▼ -404.1% |
| 2011 | -0.55x | $-20.26 Million | $37.12 Million | ▲ +6.9% |
| 2010 | -0.59x | $-26.84 Million | $45.79 Million | ▼ -177.3% |
| 2009 | 0.76x | $34.88 Million | $46.02 Million | ▲ +125.1% |
| 2008 | -3.01x | $-12.31 Million | $4.08 Million | ▼ -72.4% |
| 2007 | -1.75x | $-23.34 Million | $13.34 Million | ▼ -126.1% |
| 2006 | -0.77x | $-19.68 Million | $25.45 Million | ▼ -109.5% |
| 2005 | -0.37x | $-8.36 Million | $22.65 Million | ▲ +91.2% |
| 2004 | -4.19x | $-14.62 Million | $3.49 Million | ▲ +8.8% |
| 2003 | -4.59x | $-9.91 Million | $2.16 Million | ▲ +2.4% |
| 2002 | -4.70x | $-10.40 Million | $2.21 Million | ▼ -551.4% |
| 2001 | 1.04x | $1.25 Million | $1.20 Million | ▲ +252.1% |
| 2000 | -0.69x | $-3.97 Million | $5.80 Million | ▼ -5449.7% |
| 1999 | -0.01x | $-100.00K | $8.10 Million | ▲ +98.6% |
| 1998 | -0.91x | $-10.30 Million | $11.30 Million | ▼ -777.1% |
| 1997 | 0.13x | $1.40 Million | $10.40 Million | ▼ -61.5% |
| 1996 | 0.35x | $3.50 Million | $10.00 Million | ▲ +139.0% |
| 1995 | -0.90x | $-7.80 Million | $8.70 Million | ▼ -212.5% |
| 1994 | -0.29x | $-3.50 Million | $12.20 Million | — |